PDL-506

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePDL-506
Drug Alias NamePDL-506
ClassificationDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPhotonamic Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhotonamic Gmbh & Co Kg
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A